Yoko Nakamura

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori et al. · Hepatology · 2006 · 353 citations · Full text

Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population

Minoru Nakamura, Nao Nishida, Minae Kawashima et al. · The American Journal of Human Genetics · 2012 · 269 citations · Full text

Genome-wide Association Study, Hepatology, Liver Physiology +10

Enhanced wound healing by topical administration of mesenchymal stem cells transfected with stromal cell-derived factor-1

Yoko Nakamura, Hidefumi Ishikawa, Katsuya Kawai et al. · Biomaterials · 2013 · 160 citations · Full text

Tissue Engineering, Regenerative Medicine, Mesenchymal Stem Cells +11

Cortical correlates of false expectations during pain intensity judgments—a possible manifestation of placebo/nocebo cognitions

Jürgen Lorenz, Michael Hauck, Robert C. Paur et al. · Brain Behavior and Immunity · 2005 · 139 citations

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis

Minoru Nakamura, Yuki Shimizu‐Yoshida, Yasushi Takii et al. · Journal of Hepatology · 2004 · 126 citations

Antibody Titer, Hepatology, Autoimmune Disease +12